Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors
Clinical trial NCT07625423 · RECRUITING
Trial details
- NCT number
- NCT07625423
- Sponsor
- West China Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-27
- Primary completion
- 2028-03-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.